FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sven de Vos

Research Profile

Procedures

Gene Expression Profiling

Anatomy

Chemicals & Drugs

Devices

Oligonucleotide Array Sequence Analysis

Disorders

Physiology

Concepts & Ideas

Molecular Sequence Data

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Mary C Clark; Sven de Vos; Randy D Gascoyne; Daniel K Hsu; Fu-Tong Liu; Mabel Pang; Jonathan Said; Linda G Baum
Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death.
Saskia Gueller; Martina Komor; Daniel Nowak; Claudia D Baldus; Sven de Vos; Dieter Hoelzer; Oliver G Ottmann; Wolf-Karsten Hofmann
Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34(+) cells selected from patients with both low- and high-risk myelodysplastic syndrome.
Sven de Vos; André Goy; Shaker R Dakhil; Mansoor N Saleh; Peter McLaughlin; Robert Belt; Christopher R Flowers; Mark Knapp; Lowell Hart; Dipti Patel-Donnelly; Martha Glenn; Stephanie A Gregory; Charles Holladay; Tracy Zhang; Anthony L Boral
Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sven de Vos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Mary C Clark; Sven de Vos; Randy D Gascoyne; Daniel K Hsu; Fu-Tong Liu; Mabel Pang; Jonathan Said; Linda G Baum
Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death.
Blood 2012;120(23):4635-44.
2010: Saskia Gueller; Martina Komor; Daniel Nowak; Claudia D Baldus; Sven de Vos; Dieter Hoelzer; Oliver G Ottmann; Wolf-Karsten Hofmann
Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34(+) cells selected from patients with both low- and high-risk myelodysplastic syndrome.
Experimental hematology 2010;38(9):718-32, 732.e1-6.
2009: Sven de Vos; André Goy; Shaker R Dakhil; Mansoor N Saleh; Peter McLaughlin; Robert Belt; Christopher R Flowers; Mark Knapp; Lowell Hart; Dipti Patel-Donnelly; Martha Glenn; Stephanie A Gregory; Charles Holladay; Tracy Zhang; Anthony L Boral
Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):5023-30.
2008: Martin Allen-Auerbach; Sven de Vos; Johannes Czernin
The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients.
Radiologic clinics of North America 2008;46(2):199-211, vii.
2007: William M Suh; Zev A Wainberg; Sven de Vos; Arthur H Cohen; Ira Kurtz; Minhtri K Nguyen
Acute lymphoblastic leukemia presenting as acute renal failure.
Nature clinical practice. Nephrology 2007;3(2):106-10.
2006: Vesna Kaluza; Dinesh Rao; Jonathan W Said; Sven de Vos
Primary extranodal nasal-type natural killer/T-cell lymphoma of the brain: a case report.
Human pathology 2006;37(6):769-72.
2005: Martina Komor; Saskia Güller; Claudia D Baldus; Sven de Vos; Dieter Hoelzer; Oliver G Ottmann; Wolf-Karsten Hofmann
Transcriptional profiling of human hematopoiesis during in vitro lineage-specific differentiation.
Stem cells (Dayton, Ohio) 2005;23(8):1154-69.
2004: Seisho Takeuchi; Sven de Vos; Naoko Takeuchi; Anthony C Fermin; Thomas M Grogan; Hiromi Seo; Jonathan W Said; H Phillip Koeffler
Allelic loss during progression of follicular lymphoma.
Leukemia research 2004;28(6):567-9.
2003: Ali R Jazirehi; Xiao-Hu Gan; Sven de Vos; Christos Emmanouilides; Benjamin Bonavida
Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis.
Molecular cancer therapeutics 2003;2(11):1183-93.
2003: Sven de Vos; Utz Krug; Wolf-Karsten Hofmann; Geraldine S Pinkus; Steven H Swerdlow; William Wachsman; Thomas M Grogan; Jonathan W Said; H Phillip Koeffler
Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2003;12(1):35-43.
2003: Sven de Vos; Wolf-Karsten Hofmann; Thomas M Grogan; Utz Krug; Matthew Schrage; Thomas P Miller; Jonathan G Braun; William Wachsman; H Phillip Koeffler; Jonathan W Said
Gene expression profile of serial samples of transformed B-cell lymphomas.
Laboratory investigation; a journal of technical methods and pathology 2003;83(2):271-85.
2002: Wolf-Karsten Hofmann; Sven de Vos; Martina Komor; Dieter Hoelzer; William Wachsman; H Phillip Koeffler
Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow.
Blood 2002;100(10):3553-60.
2002: Wolf-Karsten Hofmann; Letetia C Jones; Nathan Lemp; Sven de Vos; Harald Gschaidmeier; Dieter Hoelzer; Oliver G Ottmann; H Phillip Koeffler
Ph(+) acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation.
Blood 2002;99(5):1860-2.
2002: Wolf-Karsten Hofmann; Sven de Vos; David Elashoff; Harald Gschaidmeier; Dieter Hoelzer; H Phillip Koeffler; Oliver G Ottmann
Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study.
Lancet 2002;359(9305):481-6.
2001: Wolf-Karsten Hofmann; Sven de Vos; Kunihiro Tsukasaki; William Wachsman; Geraldine S Pinkus; Jonathan W Said; H Phillip Koeffler
Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray.
Blood 2001;98(3):787-94.
1997: Sven de Vos; M I Dawson; S Holden; T Le; A Wang; S K Cho; D L Chen; H Phillip Koeffler
Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
The Prostate 1997;32(2):115-21.
1997: Sven de Vos; S Holden; David Heber; Elena Elstner; Lise Binderup; Milan Uskokovic; B Rude; D L Chen; J Le; S K Cho; H Phillip Koeffler
Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines.
The Prostate 1997;31(2):77-83.
1996: Jonathan W Said; Taizo Tasaka; Seisho Takeuchi; Hiroya Asou; Sven de Vos; E Cesarman; D M Knowles; H Phillip Koeffler
Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women.
Blood 1996;88(8):3124-8.
1996: W Said; K Chien; Seisho Takeuchi; Taizo Tasaka; Hiroya Asou; S K Cho; Sven de Vos; E Cesarman; D M Knowles; H Phillip Koeffler
Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells.
Blood 1996;87(12):4937-43.
1995: Sven de Vos; Carl W Miller; Seisho Takeuchi; A F Gombart; S K Cho; H Phillip Koeffler
Alterations of CDKN2 (p16) in non-small cell lung cancer.
Genes, chromosomes & cancer 1995;14(3):164-70.
1995: Elena Elstner; M Linker-Israeli; Jonathan Said; T Umiel; Sven de Vos; I Peter Shintaku; David Heber; Lise Binderup; M Uskokovic; H Phillip Koeffler
20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
Cancer research 1995;55(13):2822-30.
1995: Sven de Vos; C J Epstein; E Carlson; S K Cho; H Phillip Koeffler
Transgenic mice overexpressing human copper/zinc-superoxide dismutase (Cu/Zn SOD) are not resistant to endotoxic shock.
Biochemical and biophysical research communications 1995;208(2):523-31.
1995: Seppo Pakkala; Sven de Vos; Elena Elstner; R K Rude; M Uskokovic; Lise Binderup; H Phillip Koeffler
Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
Leukemia research 1995;19(1):65-72.
1994: Sven de Vos; S P Wilczynski; M Fleischhacker; P Koeffler
p53 alterations in uterine leiomyosarcomas versus leiomyomas.
Gynecologic oncology 1994;54(2):205-8.
1994: S J Jung; Young Yiul Lee; Seppo Pakkala; Sven de Vos; Elena Elstner; A W Norman; J Green; M Uskokovic; H Phillip Koeffler
1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
Leukemia research 1994;18(6):453-63.